Ethyl 2-Amino-5-Bromothiazole-4-Carboxylate

Ethyl 2-Amino-5-Bromothiazole-4-Carboxylate


    • Product Name Ethyl 2-Amino-5-Bromothiazole-4-Carboxylate
    • Alias ETHYL 2-AMINO-5-BROMOTHIAZOLE-4-CARBOXYLATE
    • Einecs 629-799-9
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    742286

    Chemical Formula C6H7BrN2O2S
    Molecular Weight 251.101
    Appearance Solid
    Melting Point 168 - 172 °C
    Boiling Point N/A
    Density N/A
    Solubility Soluble in organic solvents like DMSO, methanol
    Pka N/A
    Flash Point N/A
    Refractive Index N/A
    Odor Odorless (usually)

    As an accredited Ethyl 2-Amino-5-Bromothiazole-4-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of Ethyl 2 - Amino - 5 - Bromothiazole - 4 - Carboxylate in sealed chemical - grade pouch.
    Shipping Ethyl 2 - Amino - 5 - Bromothiazole - 4 - Carboxylate is shipped in sealed, properly labeled containers. It adheres to chemical transportation regulations, ensuring safe transit to prevent spills and maintain product integrity.
    Storage Ethyl 2 - Amino - 5 - Bromothiazole - 4 - Carboxylate should be stored in a cool, dry place, away from direct sunlight and heat sources. Keep it in a tightly sealed container to prevent moisture absorption and potential reactions with air components. Store it separately from incompatible substances, such as strong oxidizing or reducing agents, to avoid chemical reactions and ensure its stability.
    Application of Ethyl 2-Amino-5-Bromothiazole-4-Carboxylate

    Pd-Catalysed Cross-Coupling as a Gateway to Bioactive 5-Arylthiazole Libraries

    Ethyl 2-amino-5-bromothiazole-4-carboxylate functions as a privileged C5-electrophile in constructing highly decorated thiazole pharmacophores. The bromine substituent enables Suzuki–Miyaura, Sonogashira, and Buchwald–Hartwig couplings under controlled anhydrous conditions. In a representative kilo-scale campaign to produce a selective FLT3 kinase inhibitor intermediate, the aryl boronic acid coupling partner is charged at 1.15–1.25 eq relative to the bromide, with tetrakis(triphenylphosphine)palladium(0) at a loading of 0.8–1.2 mol%. Toluene/ethanol/water (3:1:1 v/v/v) serves as the biphasic solvent system, degassed by three vacuum/nitrogen purge cycles until dissolved oxygen remains below 0.5 ppm. Potassium carbonate (2.0 eq) is added as a fine powder (100–200 mesh), and the mixture is heated to 78–82 °C under a nitrogen blanket for 14–20 h. Prolonged reflux beyond 24 h triggers debromination side products, reaching up to 7% HPLC area if left unquenched. Post-reaction, the organic phase is washed with 5% w/v aqueous L-cysteine hydrochloride at 45 °C to scavenge residual palladium, achieving final Pd levels below 10 ppm as verified by ICP-MS per USP 〈233〉. The crude product is concentrated and recrystallised from isopropanol/water (7:3) to deliver the 5-arylthiazole ester with >99.5 area-% purity and a single impurity threshold of 0.10% at 220 nm. Manufacturing must comply with ICH Q7 for active pharmaceutical ingredient (API) starting materials, with residual solvents controlled under ICH Q3C Option 2 limits — toluene 890 ppm, ethanol 5000 ppm — and the absence of mutagenic impurities confirmed by AMES testing in accordance with ICH M7. Equipment trains typically consist of glass-lined reactors with Hastelloy C-22 agitators, double mechanical seals, and online Karl Fischer moisture analysis maintaining water content below 50 µg/g during charging. The terminal active pharmaceutical ingredient is an orally bioavailable type III receptor tyrosine kinase inhibitor undergoing Phase IIb evaluation; two related Investigational New Drug applications cross-reference this thiazole building block in DMFs filed with the US FDA.

    Side reactions arising from the free amino group pose a recognised operational risk. Acetylation of the 2-NH₂ with acetic anhydride prior to coupling, followed by deprotection with 6 N HCl in dioxane at 60 °C, is recommended when electron-deficient aryl boronic acids are employed, as otherwise intramolecular coordination retards transmetallation. This protection-deblock protocol adds 18–24 h to the synthetic route and requires rigorous exclusion of moisture to prevent premature hydrolysis of the ethyl ester. A less common but documented alternative omits protection: using XPhos Pd G3 ( 0.2 mol%) in wet THF containing 2.5 eq K₃PO₄, achieving 88–92% isolated yield on 500 mmol scale, though industrial-scale adoption remains limited due to the higher cost of the precatalyst and a narrower processing window — reaction temperatures exceeding 55 °C cause rapid catalyst decomposition and palladium black precipitation, fouling heat transfer surfaces on jacket-heated vessels.

    Conversion of the ethyl ester moiety into a carboxylic acid intermediate represents the most common downstream functionalisation for agrochemical lead optimisation. The free acid is accessed by saponification with lithium hydroxide monohydrate (2.2 eq) in tetrahydrofuran/water (4:1), stirred at 20–25 °C for 6–8 h. Temperature moderation is critical: exotherms above 35 °C generate 2-amino-5-bromo-4-thiazolecarboxylic acid in reduced yield owing to decarboxylation, the rate of which doubles for every 8 °C increment above 30 °C according to reaction calorimetry data. After acidification to pH 2.5 with 3 N hydrochloric acid at 0–5 °C, the precipitated acid is isolated by centrifugation and dried under vacuum (—0.09 MPa, 40 °C, 12 h). This intermediate is then activated as its acid chloride using thionyl chloride (1.5 eq) in dichloromethane with catalytic dimethylformamide (0.05 eq), and immediately quenched with an appropriately substituted aniline to furnish a 2-amino-5-bromothiazole-4-carboxamide scaffold. In a pilot-plant campaign for a novel succinate dehydrogenase inhibitor (SDHI) fungicide candidate, the amidation was conducted as a one-pot sequence in a 200 L glass-lined reactor equipped with a caustic scrubber loop to neutralise SO₂ off-gas. The resulting off-white wet cake was slurried in deionised water at 60 °C for 1 h to reduce chloride ion content below 200 ppm, a prerequisite to avoid phytotoxicity in greenhouse screening. Analytical release specifications follow CIPAC MT 178 for purity (> 98%), loss on drying (0.5% max), and water content by Karl Fischer (0.3% max). Any shipment destined for North American registration requires a full five-batch analysis demonstrating consistency of the impurity profile as per US EPA 40 CFR Part 158 guidelines for biochemical pesticide intermediates.

    Diazotisation and the Formation of Monoazo Disperse Dyes with High Wash Fastness

    The electron-deficient thiazole nucleus, when positioned as a diazo component, produces bathochromically shifted disperse dyes with extinction coefficients exceeding 4.0 × 10⁴ L mol⁻¹ cm⁻¹ in acetone. Ethyl 2-amino-5-bromothiazole-4-carboxylate is diazotised at 0–5 °C by dissolution in concentrated sulfuric acid (98%, 3.0 parts by weight) followed by slow addition of nitrosylsulfuric acid (40% w/w in H₂SO₄, 1.05 eq). The mixture is stirred for 2 h while maintaining a temperature below 8 °C; a positive nitrite test on starch-iodide paper after 30 min confirms completion. The resulting diazonium salt solution is diluted with a chilled mixture of sulfamic acid (0.5% w/v) and crushed ice to destroy excess nitrous acid, and then coupled immediately with an N,N-diethyl-m-toluidine-based coupling component dissolved in dilute hydrochloric acid at pH 2.0–2.8. Coupling proceeds within 15–30 min under vigorous dispersion using a rotor-stator homogeniser operating at 3000 rpm to avoid tar formation at the organic-aqueous interface. The precipitated dye is filtered, washed to neutral pH, and oven-dried at 60 °C to a moisture content below 1.0%. The bromine atom in the 5-position increases both tinctorial strength and sublimation fastness on polyester; when dyed at 130 °C under high-temperature exhaust conditions, the resulting fabric withstands ISO 105-C06 C2S washing without staining adjacent multifibre beyond grey scale rating 4–5. Finished product must comply with the ZDHC Manufacturing Restricted Substances List, with limits on arylamines (EN 14362-1: 20 mg/kg per amine), chlorinated phenols (ISO 17070: 0.5 mg/kg), and heavy metals (OEKO-TEX Standard 100 Annex 4, with leachable antimony 30 mg/kg). Dispersion quality is verified by filtering a 5% aqueous dispersion over a 5 µm disc filter under 0.2 bar pressure: filter residue shall not exceed 0.02% of the dye weight.

    One recurring processing bottleneck arises when scaling diazotisation beyond 50 kg batches. The exotherm from nitrosylsulfuric acid addition is not linearly scalable, and in 500 L jacketed vessels the internal temperature can spike from 2 °C to 18 °C within 45 seconds if brine circulation fails momentarily. Such deviations generate deamination byproducts identifiable at 4.3 min retention time by HPLC, which cannot be removed by recrystallisation and permanently shift the shade of the final dye toward redder hues. Facilities routinely install redundant cooling systems and program the PLC to halt dosing when the jacket outlet temperature exceeds —5 °C. In addition, residual ethyl acetate from earlier synthetic steps must be removed by vacuum stripping to below 200 ppm; even traces react with the nitrosating agent, forming ethyl nitrite that pressurises closed vessels and presents a deflagration hazard. Safety relief systems are sized for a 10-bar g event as per DIERS methodology, and the vent stream is routed to a water scrubber where ethyl nitrite is hydrolysed.

    Incorporation of the brominated thiazole nucleus into a polyurethane backbone can impart intrinsic flame retardancy without the migration issues observed with low-molecular-weight additive flame retardants. The 2-amino group reacts with methylene diphenyl diisocyanate (MDI) at an isocyanate index of 1.02–1.05 in a two-shot prepolymer process. In a typical formulation, a polyether polyol (OH value 28 mg KOH/g, functionality 3) is blended with the thiazole ester at a loading of 8–12% w/w relative to total polyol, together with a silicone surfactant (1.0 phr) and a blowing catalyst (Dabco 33-LV, 0.3 phr). The blend is pre-heated to 40 °C and mixed with a stoichiometric amount of polymeric MDI (NCO content 31.5%) using a low-pressure metering machine fitted with a pin mixer rotating at 4500 rpm. Cream time at 25 °C extends from a standard 18 s to 27 s due to the electron-withdrawing effect of the thiazole ring slowing urea formation; this is partially offset by adjusting the tin catalyst (stannous octoate) from 0.08 phr to 0.15 phr. The resulting flexible foam achieves a V-0 classification under UL 94 vertical burn testing at a density of 28 kg/m³, with a limiting oxygen index (LOI) of 26.8% measured per ASTM D2863-19. Critically, no exudation is observed after 7 days at 80 °C in a Heraeus forced-convection oven, confirming covalent incorporation into the polymer matrix. The ethyl ester group remains largely pendant and can undergo limited transesterification with polyol hydroxyls at foam cure temperatures above 160 °C, which slightly increases crosslink density — this must be accounted for when designing formulations for molded seating applications where compression set (ASTM D3574-17 Test H) must stay below 10%. Process safety: this compound should not be pre-mixed with amine-based polyols containing free tertiary amine catalysts for more than 2 h at 30 °C, as slow carbamate formation consumes NCO capacity prematurely and generates CO₂ bubbles within the metering line, degrading shot-to-shot weight consistency beyond ±1.5%. EU REACH regulation (EC) No 1907/2006 requires registration of the substance as an intermediate used under strictly controlled conditions if manufactured or imported above 1 tonne/year, and flame-retarded end articles sold in the EU must comply with the RoHS recast (Directive 2011/65/EU) bromine exemption thresholds for polymeric applications.

    Melt Inactivation: Stabilising Silver Halide Microcrystals in Colour Photothermographic Films

    A narrow but technologically demanding application exploits the silver-complexing affinity of the thiazole nitrogen and the exocyclic amine. In dry photothermographic media destined for medical X-ray hard copy output, ethyl 2-amino-5-bromothiazole-4-carboxylate is added to the silver soap/behenate dispersion at 0.03–0.08 mol per mole of silver behenate. This compound functions as a melt-phase development inhibitor, selective for unexposed silver halide grains during thermal processing at 122–128 °C. The inhibitor is dissolved in methyl ethyl ketone together with the binder (polyvinyl butyral, 8% w/v) and a phthalazine-based developer, then coated on a blue-tinted polyester base via a slot-die at 150 m/min. The wet film passes through a three-zone drying oven ramping from 40 °C to 85 °C, after which total residual solvent is maintained below 0.2 mg/m². During thermal development, the brominated thiazole suppresses fog by forming a transient coordination complex with Ag⁺ ions released from unexposed grains, retarding the reduction to metallic silver. The bromine substituent elevates the melting point of the complex relative to the unchlorinated analogue — differential scanning calorimetry shows an endothermic dissociation peak at 147 °C, well above the maximum processing temperature, ensuring it remains intact throughout development. Shelf-life stability testing per ISO 18902:2013 requires incubation at 50 °C/80% RH for 14 days, after which fog density measured by a calibrated reflection densitometer must increase by less than 0.04 optical density units. Regular production batches are monitored for silver halide crystal morphology using transmission electron microscopy at 100 keV: any batch of the thiazole inhibitor that introduces crystal habit variation (measured as aspect ratio shift by more than 0.15) is rejected, because anisotropic grain growth alters sensitometric response and DICOM greyscale conformance under ISO 12052. Given the diminishing market for photothermographic film, supply chain continuity for this niche additive depends on long-term contracts with a single qualified supplier holding a drug master file-type dossier documenting the substance’s synthesis and purification history under GMP for pharmaceutical excipients, even though the end use is non-pharmaceutical; such regulatory rigour is driven by the zero-tolerance for batch-to-batch variation in image quality.

    Trace metal contamination — particularly iron above 15 ppm and copper above 5 ppm — catalyses the premature reduction of silver ions during coating storage, manifesting as randomly distributed pepper fog within 48 h of manufacture. The thiazole ester is consequently purified by treatment with a chelating resin (Chelex 100, sodium form) in ethanolic solution prior to final crystallisation, targeting a final transition metal burden of less than 5 ppm by total reflection X-ray fluorescence (TXRF). The purified product is stored under argon in amber glass containers at —20 °C to prevent oxidative dimerisation at the 2-amino position, which is detectable as a new peak at 380 nm in the UV-Vis spectrum and renders the entire batch unusable for sensitometric coatings.

    Can a Single Reagent Distinguish Pd(II) from Pt(II) via Ligand-to-Metal Charge Transfer?

    Ethyl 2-amino-5-bromothiazole-4-carboxylate acts as a selective chromogenic ligand for palladium(II) in highly acidic chloride media. Dissolved in ethanol at 0.10% w/v and acidified with 2 M hydrochloric acid, the reagent forms a yellow 1:2 metal-to-ligand complex with PdCl₄²⁻, exhibiting an absorbance maximum at 412 nm and a molar absorptivity of 1.8 × 10⁴ L mol⁻¹ cm⁻¹. Platinum(IV), even at a ten-fold molar excess, produces no spectral shift, allowing direct spectrophotometric determination of palladium in spent petrochemical catalyst leachates. Calibration is linear over the range 0.2–10 µg/mL Pd with a detection limit of 0.06 µg/mL calculated per ICH Q2(R2) signal-to-noise methodology. The analysis tolerates up to 1000 mg/L of nickel and cobalt without interference, but iron(III) must be masked with 0.1 M phosphate. For process monitoring in a precious metals refinery, the method replaces time-consuming fire assay for batch release of recycled palladium sponge, provided the sample solution is filtered through a 0.22 µm PVDF syringe filter to remove insoluble residues that scatter the incident beam.

    Free Quote

    Competitive Ethyl 2-Amino-5-Bromothiazole-4-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    Ethyl 2-amino-5-bromothiazole-4-carboxylate (CAS 61830-21-5, molecular weight 251.10 g·mol⁻¹, formula C₆H₇BrN₂O₂S) functions as a densely functionalized heterocyclic scaffold routinely deployed in the construction of kinase inhibitor libraries and antibacterial programmes targeting Gram-negative topoisomerases. The electron‑withdrawing 4‑carboxylate ester activates the thiazole ring toward nucleophilic aromatic substitution at the 5‑position while the free 2‑amine serves as a pendant nucleophile for amide or urea coupling. In a typical discovery chemistry setting, material screened at 95% HPLC purity (UV detection at 254 nm) is upgraded to ≥99.0% by trituration in cold isopropanol before use in palladium‑mediated transformations, a precaution that removes the des‑bromo impurity known to poison Buchwald‑Hartwig catalysts.

    Why Does Halogen Identity Dictate Cross‑Coupling Efficiency in 2‑Aminothiazole‑4‑Carboxylate Scaffolds?

    The bromine atom at C‑5 occupies a kinetic sweet spot that is difficult to replicate with chlorine or iodine. Comparative screening under identical microwave‑assisted Suzuki‑Miyaura conditions (Pd(PPh₃)₄ 2 mol%, K₂CO₃ 3.0 eq, DMF/H₂O 4:1 v/v, 110 °C) shows the 5‑chloro analogue reaches <20% conversion after 2 h because the C–Cl bond (bond dissociation energy ≈ 96 kcal·mol⁻¹) resists oxidative addition to Pd⁰. The 5‑iodo analogue achieves >98% conversion within 30 min but generates 3–5 area% of the dehalogenated by‑product, attributed to rapid β‑hydride elimination from the incipient Pd‑aryl intermediate. The 5‑bromo compound, with a C–Br bond dissociation energy of approximately 81 kcal·mol⁻¹, typically delivers 91–94% isolated yield of the cross‑coupled product with <1% des‑bromo impurity when the reaction is quenched at 2 h. This window of reactivity—fast enough to permit complete conversion within a practical cycle time yet sufficiently controlled to suppress protodebromination—directly lowers the burden of preparative HPLC purification in hit‑to‑lead libraries. During pilot‑plant campaigns at the 50–100 kg scale, the crystalline habit of the compound simplifies isolation. Cooling a warm ethyl acetate solution from 55 °C to 0 °C at a rate of 10 °C·h⁻¹ yields off‑white prisms with a median particle size D₅₀ of 120–180 µm, which filter rapidly on a Nutsche filter under 0.3 bar of vacuum. The low residual palladium specification—typically <10 ppm as measured by ICP‑OES after a charcoal treatment—is essential for intermediates destined for active pharmaceutical ingredient (API) starting material status in accordance with ICH Q3D.
    Specification targets for a multi‑kilogram GMP starting material lot
    ParameterTest methodTypical value
    AppearanceVisual inspectionOff‑white to pale yellow crystalline powder
    Purity (HPLC)USP <621> (C18, 150 × 4.6 mm, 5 µm; acetonitrile/water 70:30 + 0.1% TFA; 254 nm)≥99.3 area%
    Loss on dryingUSP <731> (70 °C, vacuum)≤0.5%
    Heavy metalsUSP <231>≤20 ppm
    Residual solventsHeadspace GC‑FID (internal method, ICH Q3C limits)Ethanol < 5000 ppm; ethyl acetate < 5000 ppm
    2‑Amino‑5‑bromothiazole‑4‑carboxylic acidHPLC (same conditions as purity)≤0.10 area%
    Any unspecified impurityHPLC≤0.10 area%

    Ensuring Batch‑to‑Batch Consistency in Multi‑Kilogram Campaigns

    Operators must account for the exothermic nature of the esterification step that formally gives the title compound, because uncontrolled thermal excursions above 85 °C initiate decarboxylative debromination. On a 200 L glass‑lined reactor equipped with a retreat‑curve impeller, maintaining the internal temperature at 60–65 °C while adding thionyl chloride (1.05 eq) to a suspension of 2‑amino‑5‑bromothiazole‑4‑carboxylic acid in absolute ethanol reproducibly generates crude product with ≤0.3% of the decarboxylated impurity. After aqueous work‑up, the damp cake must be dried under an inert nitrogen sweep at ≤40 °C; prolonged exposure to temperatures above 50 °C even in the dry state leads to observable sublimation losses of 0.2–0.5 wt% per hour, as documented during thermogravimetric analysis (TGA) heating at 5 °C·min⁻¹. Exposure to ambient humidity exceeding 60% RH accelerates hydrolysis of the ethyl ester to the corresponding carboxylic acid. In an accelerated stability study conducted according to ICH Q1A guidelines (40 °C/75% RH, open dish), the acid impurity reaches 0.8 area% after 30 days. Double‑bagging the product in anti‑static LDPE liners inside a fibre drum with a desiccant capsule restricts the acid impurity to <0.2% over the same interval. Consequently, the material is recommended to be handled in an environment where the dew point does not exceed −20 °C.
    Comparative reactivity of 5‑halo‑2‑aminothiazole‑4‑carboxylate esters in palladium‑catalysed cross‑coupling (Suzuki‑Miyaura with phenylboronic acid; Pd(PPh₃)₄ 2 mol%, K₂CO₃, DMF/H₂O 4:1, 80 °C)
    5‑SubstituentConversion after 2 h (%)Isolated yield (%)Protodehalogenation by‑product (%)
    Cl18<10<1
    Br97910.8
    I99884.5
    When the target architecture requires a free carboxylic acid rather than the ethyl ester, saponification of ethyl 2‑amino‑5‑bromothiazole‑4‑carboxylate with LiOH in THF/water (3:1) at 0 °C proceeds cleanly, avoiding the competing nucleophilic displacement of the bromine substituent that hot alkaline conditions provoke. The resulting acid demonstrates poor solubility in most organic solvents (<2 mg·mL⁻¹ in DMSO, <1 mg·mL⁻¹ in ethanol at 25 °C), which limits its direct use in solution‑phase amide coupling without pre‑neutralisation with tetrabutylammonium hydroxide. In contrast, the ethyl ester maintains solubility of ≥50 mg·mL⁻¹ in dichloromethane, tetrahydrofuran, and dimethylformamide, enabling homogeneous coupling conditions with HATU/DIPEA at 0.5 M substrate concentration without precipitation of the activated ester.

    When Is the 5‑Bromo Analogue Preferred Over the 5‑Iodo for Large‑Scale Amidation?

    Vendor‑supplied 5‑iodo‑2‑aminothiazole‑4‑carboxylate esters frequently arrive with 2–5% of the de‑iodinated impurity already present, a consequence of the weaker C–I bond. During a Buchwald‑Hartwig amination screening with morpholine using Xantphos Pd G3 precatalyst (1 mol%), the 5‑bromo substrate delivers 87% assay yield after 4 h at 80 °C, while the 5‑iodo congener provides only 72% because competing proto‑deiodination diverts catalyst turnover. When the amination is performed at intramural CMC (chemistry, manufacturing, and controls) stage, the bromo derivative’s resistance to adventitious reductive dehalogenation simplifies the control strategy for the critical impurity 2‑aminothiazole‑4‑carboxylate, which is routinely kept below 0.15% by area. The cost differential also scales non‑linearly: the 5‑iodo compound can command a price 2‑ to 3‑fold higher than the 5‑bromo because the starting 5‑iodothiazole‑4‑carboxylic acid requires electrophilic iodination using N‑iodosuccinimide under strongly acidic conditions that demand specialised corrosion‑resistant equipment. The bromination step for the 5‑bromo intermediate, by comparison, is performed with molecular bromine in acetic acid at 0–10 °C in standard glass‑lined reactors. As a result, procurement lead times for 50 kg of the bromo derivative from Asian contract manufacturers typically fall within 6–8 weeks, versus 12–14 weeks for the iodo analogue. Residual bromide ion in the isolated product must be controlled below 50 ppm when the downstream API manufacturing process includes a silver‑mediated cyclisation, because silver bromide precipitation sequesters the metal catalyst. Ion chromatography (Dionex ICS‑5000, AS19 column) with suppressed conductivity detection achieves a limit of quantitation of 5 ppm for bromide, and routine aqueous washes of the final organic solution with 5 wt% sodium bicarbonate reduce residual inorganic bromide from 200–500 ppm to <30 ppm. In campaigns where the subsequent transformation employs a copper‑mediated Ullmann coupling, residual bromide levels below 100 ppm are acceptable, but copper‑catalyzed homocoupling side reactions are noticeably attenuated at bromide concentrations below 20 ppm, as evidenced by reaction calorimetry data showing an induction period that lengthens by 15–20 min when bromide is thoroughly depleted. Monitoring for the genotoxic impurity 2‑amino‑5‑bromothiazole—the des‑ester derivative formed through retro‑esterification—is executed by LC‑MS on a single quadrupole instrument operating in selected ion monitoring mode (m/z 177.0 [M+H]⁺). A column with phenyl‑hexyl stationary phase (100 mm × 3.0 mm, 2.7 µm) resolves this impurity from the main peak with a selectivity factor α of 1.8. The validated method achieves an LOQ of 0.05% relative to the main component, satisfying the ICH M7 (R1) threshold for a compound dosed at ≤1 g·day⁻¹. During a 12‑month stability study at long‑term storage conditions (25 °C/60% RH), the des‑ester impurity remained below the reporting threshold in all three pilot batches, confirming that the double‑bagged, desiccant‑protected packaging configuration is fit for purpose. No other commercially available 2‑aminothiazole‑4‑carboxylate exhibits the same vector of reactivity, cost, and impurity control. The 5‑fluoro analogue, while electronically intriguing, suffers from a challenging deoxofluorination step that yields a complex impurity profile, whereas the 5‑unsubstituted parent lacks a synthetic handle for iterative diversification. As generic entry into this chemical space expands, the 5‑bromo derivative has become the default starting point for C‑5 elaborated thiazole libraries, unseating the 5‑chloro congener that had dominated early‑stage medicinal chemistry collections purely on price grounds.